- President Trump accuses insurance companies of profiting excessively from ACA subsidies, proposing federal funds go directly to individuals instead.
- Enhanced ACA tax credits are set to expire, potentially raising premiums by 26% for many recipients amid ongoing government shutdown negotiations.
- Health insurance industry profits remain low under ACA caps, with over 24.3 million marketplace enrollees facing affordability concerns.
In a prime-time address on December 17, 2025, President Donald Trump doubled down on claims made earlier on Truth Social, asserting that the Affordable Care Act was "created to make insurance companies rich" and calling for subsidy funds to "go to the people" rather than insurers. This rhetoric comes as enhanced ACA tax credits are poised to expire, which could spike premiums by an average of 26% for many Americans, according to recent analyses. The speech followed a November 8 Truth Social post where Trump urged Senate Republicans to send "hundreds of billions" directly to individuals for healthcare, bypassing what he termed "money sucking Insurance Companies."
Efforts to restructure healthcare funding have hit a snag amid a government shutdown over spending priorities. House Republicans passed a bill with GOP health care changes but did not include an extension of the subsidies, while the Senate advanced a spending package on November 10 that could lead to a vote on extensions in December, according to people familiar with the matter. Without a deal, millions of marketplace users would face significant premium hikes, adding pressure to ongoing negotiations.
The U.S. health insurance industry, including giants like UnitedHealth Group (UNH) and Anthem (ANTM), has seen enrollment surge to over 24.3 million ACA marketplace participants in 2025, doubled since 2020 due to subsidies. However, profit margins were just 0.8% in 2024, representing 0.5% of national health expenditures in 2023, under ACA medical loss ratio rules that cap administrative costs and profits at 15-20% of premiums. In response to Trump's accusations, AHIP CEO defended insurers' role in cost control, stating in a recent interview that the industry helps shield consumers from rising medical expenses. Attempts to reach other industry leaders for comment were unsuccessful.
Market dynamics are shifting as the expiration deadline looms. Over 75% of adults support keeping the subsidies, per recent polls, highlighting public concern over affordability. Trump's proposal aligns with GOP resistance to extending subsidies, favoring alternatives like health savings accounts, though he has previously pledged to improve, not repeal, the ACA. Fact-checks have rated his claim that the ACA was designed to enrich insurers as misleading, noting that while subsidies benefited companies, strict caps limit excessive profits. This ties into broader political maneuvers, including Trump's "Big, Beautiful Bill Act" funding other priorities such as military payments.
Looking ahead, short-term implications hinge on the Senate's potential December vote if the shutdown ends, with experts warning of premium spikes without an extension. Long-term, Trump's push for reforms could redirect funds, alongside initiatives like TrumpRx for direct drug sales and his Fed chair nomination aimed at lower rates. Industry insiders note that low insurer margins challenge the narrative of "ripping off," but the debate continues to spark discussions on healthcare access versus corporate profits. In a related development, Trump has also linked the issue to military payouts, with $2.6 billion in "warrior dividends" funded partly by tariffs, adding another layer to the economic landscape.
Correction: An earlier version misstated the profit margin percentage; it has been updated to reflect 0.8% in 2024.
